Additional file 1 of Association of apolipoproteins and lipoprotein(a) with metabolic syndrome: a systematic review and meta-analysis
Creators: name: Ulloque-Badaracco, Juan R.
name: Al-kassab-Córdova, Ali
name: Hernandez-Bustamante, Enrique A.
name: Alarcon-Braga, Esteban A.
name: Huayta-Cortez, Miguel
name: Carballo-Tello, Ximena L.
name: Seminario-Amez, Rosa A.
name: Herrera-Añazco, Percy
name: Benites-Zapata, Vicente A.
Publisher: name: figshare
Year: 2024
Subjects: Medicine
Molecular Biology
Mathematical Sciences not elsewhere classified
Cancer
Science Policy
Hematology
Computational Biology

description: Additional file 1: Table S1. Search strategies. Table S2. Criteria for clinical diagnosis of metabolic syndrome used in the included studies. Table S3. Quality assessment of included studies. Figure S1. Subgroup analysis according to assay method of the association between ApoB levels and MetS. Figure S2. Subgroup analysis according to diagnostic criteria of the association between ApoB levels and MetS. Figure S3. Subgroup analysis according to sex of the association between ApoB levels and MetS. Figure S4. Subgroup analysis according to continents of the association between ApoB levels and MetS. Figure S5. Subgroup analysis according to study design of the association between ApoB levels and MetS. Figure S6. Sensitivity analysis according to risk of bias of the association between ApoB levels and MetS. Figure S7. Subgroup analysis according to assay method of the association between ApoA1 levels and MetS. Figure S8. Subgroup analysis according to diagnostic criteria of the association between ApoA1 levels and MetS. Figure S9. Subgroup analysis according to sex of the association between ApoA1 levels and MetS. Figure S10. Subgroup analysis according to continents of the association between ApoA1 levels and MetS. Figure S11. Subgroup analysis according to study design of the association between ApoA1 levels and MetS. Figure S12. Sensitivity analysis according to risk of bias of the association between ApoA1 levels and MetS. Figure S13. Subgroup analysis according to diagnostic criteria of the association between ApoB/ApoA1 ratio levels and MetS. Figure S14. Subgroup analysis according to gender of the association between ApoB/ApoA1 ratio levels and MetS. Figure S15. Subgroup analysis according to continents of the association between ApoB/ApoA1 ratio levels and MetS. Figure S16. Subgroup analysis according to study design of the association between ApoB/ApoA1 ratio levels and MetS. Figure S17. Sensitivity analysis according to risk of bias of the association between ApoB/ApoA1 ratio levels and MetS. Figure S18. Subgroup analysis according to assay method of the association between lipoprotein(a) levels and MetS. Figure S19. Subgroup analysis according to diagnostic criteria of the association between lipoprotein(a) levels and MetS. Figure S20. Subgroup analysis according to continents of the association between lipoprotein(a) levels and MetS. Figure S21. Subgroup analysis according to study design of the association between lipoprotein(a) levels and MetS. Figure S22. Sensitivity analysis according to risk of bias of the association between lipoprotein(a) levels and MetS. Figure S23. Funnel Plot of the studies that evaluated the association between ApoB and MetS. Figure S24. Funnel Plot of the studies that evaluated the association between ApoA1 and MetS. Figure S25. Funnel Plot of the studies that evaluated the association between ApoB/ApoA1 ratio and MetS. Figure S26. Funnel Plot of the studies that evaluated the association between Lipoprotein(a) and MetS.